FDA approves Merck's kidney disease treatment - CSL Recruitment PDF Print
CSL Recruitment
The approval from the FDA came after the publication of results from the Study of Heart and Renal Protection (Sharp). Dr Mendelsohn added: "The results of Sharp as described in the new label for Vytorin can help the medical community understand the ...
New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.